Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Airing is a private U.S. medical device company developing a miniaturized micro-CPAP system for obstructive sleep apnea. Its core concept is a hoseless, maskless, cordless, battery-powered device intended to deliver positive airway pressure through nasal buds as an alternative to conventional CPAP equipment. The company has also described an Airing SmartMask product concept built around an exhalation valve, pressure sensing, and breathing-responsive control technology derived from its micro-CPAP development work. As of the latest public company materials, the micro-CPAP remains in development and is not yet commercially available or FDA approved. Airing appears to be focused on improving patient comfort and adherence in sleep apnea treatment rather than developing drugs or biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Airing.